China NMPA Product Recall - Electronic blood pressure monitor (model HEM-7312)

Omron (Dalian) Co., Ltd. has initiated a voluntary Class III recall of its Electronic Blood Pressure Monitor, Model HEM-7312. This action, publicly announced on December 17, 2018, by the National Medical Products Administration (NMPA), stems from identified non-compliance issues concerning the device's labeling. Specifically, the product failed to meet the 'labeling requirements' stipulated by industry standard YY0670-2008. Additionally, it did not adhere to the technical specifications outlined in its official registration document, Liaoning Medical Device Registration Certificate 20162200100. The regulatory framework governing this recall involves the NMPA, which oversees medical device safety and compliance. Omron (Dalian) Co., Ltd.'s decision to recall the product reflects its responsibility to rectify these non-conformities. While specific inspection dates leading to an enforcement action are not detailed, the voluntary nature of the recall indicates the company's proactive response to identified discrepancies. The primary required action is the retrieval of all affected HEM-7312 electronic blood pressure monitors from the market, ensuring that products available to consumers meet all applicable safety and labeling standards. Further details regarding specific affected units and additional actions are available in the 'Medical Device Recall Event Report Form.' This recall underscores the importance of stringent adherence to established medical device standards to safeguard public health.